Where does Medisca Pharmaceutique Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Medisca Pharmaceutique Inc. ranks #12,114 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Medisca Pharmaceutique Inc. hold?

Medisca Pharmaceutique Inc. holds 25 US utility patents granted between 2016 and 2025, spanning 15 technology areas.

What is Medisca Pharmaceutique Inc.'s Innovation Score?

Medisca Pharmaceutique Inc. has an Innovation Score of 38.2 out of 100 (top 41% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Medisca Pharmaceutique Inc. focus on?

Medisca Pharmaceutique Inc.'s top technology area is B01F (Mixing, e.g. Dissolving, Emulsifying OR Dispersing) with 15 patents, ranking #45 of 1,218 assignees active in that subclass. Grants appear in 15 CPC subclasses total.

Is Medisca Pharmaceutique Inc.'s patent grant rate increasing or decreasing?

Medisca Pharmaceutique Inc.'s recent grant velocity is +86% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for Medisca Pharmaceutique Inc.'s patents?

Medisca Pharmaceutique Inc.'s patents average 17.5 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Medisca Pharmaceutique Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Medisca Pharmaceutique Inc.

USPTO PatentsView assignee record - 25 granted patents across 15 technology areas, recorded in grant years 2016–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: B01F (Mixing, e.g. Dissolving, Emulsifying OR Dispersing).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Medisca ranks #12,114 of 49,997 tracked US assignees by granted-patent volume, with 25 patents across 15 technology areas.

#12,114
of 49,997 US assignees by volume: Top 41%
by Innovation Score (38.2/100): 17.5
avg claims per patent: +86%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R12114 · Foreign Corporation #12,114 · 25 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL

GRANTS-SMALL 25 grants
UPPER-Q #12,114/49,997
PHOTO-FINISH Mapi Pharma
CPC-FOCUS B01F · 15 areas
INNOV-THIN 38.2/100
CLAIMS-RICH 17.5 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-SURGE +86% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Mapi Pharma Ltd. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Medisca’s 38.2 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 11.3 pts (30%) Velocity 2.8 pts (7%) Breadth 13.7 pts (36%) Claim depth 10.5 pts (27%)

Qualcomm Incorporated · highest

85
American Internation… · near

38
Honey BEE Manufactur… · near

38
Legrand AV · near

38
Medisca Pharmaceutique · this assignee

38
Ziemer Ophthalmic… · near

38
3D Lighting… · lowest

7

What this shows Medisca's Innovation Score is 38.2/100 (top 41% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Medisca?

Each dot is one of Medisca’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Medisca’s own 17.5 claims/patent is ABOVE the 17.4 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Medisca vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Medisca's grants concentrate

Medisca Pharmaceutique Inc. is a focused PatentsView assignee: 15 CPC subclasses with 60% of grants classified under B01F (Mixing, e.g. Dissolving, Emulsifying OR Dispersing). Peak complete grant year is 2021 (5 grants) versus a trough of 1 in 2017. By volume, Medisca sits between Mapi Pharma Ltd. and Ming Shin Tools Co., Ltd..

Medisca's three-year grant acceleration

Medisca Pharmaceutique Inc. shows 5 grants in 2022–2024 against only 12 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Mapi Pharma

25
Meas France

25
Mediamath

25
Medinstill Develo…

25
Metabolon

25
Mighty Fire Break…

25
Minerva Biotechno…

25
Ming Shin Tools

25
Medisca Pharmaceu… ◀

25

What this shows Medisca holds 25 patents at rank #12,109, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Medisca

By rank, the assignees closest to #12,109 in granted patent volume.

Leaders in B01F (Mixing)

Other assignees with the most granted patents in Medisca's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Medisca, neither rank-band nor same-CPC leaders (those blocks stay above). In B01F (Mixing), Medisca ranks #45 of 1,218 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (38 here).

Honey BEE Manufacturing Ltd. 38 Legrand AV Inc. 38 American International Group, Inc. 38 Ziemer Ophthalmic Systems AG 38

Medisca's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

38 Top 41% higher than 59% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2016–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.

View data table

Medisca Pharmaceutique Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2016	2	8.0%
2017	1	4.0%
2019	4	16.0%
2020	3	12.0%
2021	5	20.0%
2023	2	8.0%
2024	3	12.0%
2025partial year	5	20.0%

Which technologies does Medisca Pharmaceutique Inc. patent most?

B01F - Mixing, e.g. Dissolving, Emulsifying OR Dispersing 15

A61J - Containers Specially Adapted FOR Medical OR Pharmaceutical PURPOSES; Devices OR Methods Specially Adapted FOR Bringing Pharmaceutical Products Into Particular Physical OR Administering FORMS; Devices FOR Administering Food OR Medicines ORALLY; Baby COMFORTERS; Devices FOR Receiving Spittle 13

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 13

B65B - Machines, Apparatus OR Devices FOR, OR Methods OF, Packaging Articles OR MATERIALS; Unpacking 11

B29B - Preparation OR Pretreatment OF THE Material TO BE SHAPED; Making Granules OR PREFORMS; Recovery OF Plastics OR Other Constituents OF Waste Material Containing Plastics 11

G16C - Computational CHEMISTRY; CHEMOINFORMATICS; Computational Materials Science 2

A61Q - Specific USE OF Cosmetics OR Similar Toiletry Preparations 2

G06Q - Information AND Communication Technology [ICT] Specially Adapted FOR Administrative, Commercial, Financial, Managerial OR Supervisory PURPOSES; Systems OR Methods Specially Adapted FOR Administrative, Commercial, Financial, Managerial OR Supervisory Purposes, NOT Otherwise Provided FOR 2

G06F - Electric Digital Data Processing 1

G06K - Graphical Data Reading ; Presentation OF DATA; Record CARRIERS; Handling Record Carriers 1

G16H - Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data 1

B05C - Apparatus FOR Applying Fluent Materials TO Surfaces, IN General 1

B05B - Spraying APPARATUS; Atomising APPARATUS; Nozzles 1

F16J - Pistons ; CYLINDERS; Sealings 1

B65D - Containers FOR Storage OR Transport OF Articles OR Materials, e.g. Bags, Barrels, Bottles, Boxes, Cans, Cartons, Crates, Drums, Jars, Tanks, Hoppers, Forwarding CONTAINERS; Accessories, Closures, OR Fittings THEREFOR; Packaging ELEMENTS; Packages 1

Top 15 of 15 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Medisca Pharmaceutique Inc.'s patent record in context - here's where to go next.

Medisca Pharmaceutique Inc.'s lead technology class is B01F (Mixing, e.g. Dissolving, Emulsifying OR Dispersing), 60% of its portfolio - see every assignee active in that class. Explore B01F
Ranked #12,114 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Medisca Pharmaceutique Inc. against Mapi Pharma Ltd., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 38.2/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.